Project details
- Project period
- 1 Oct 2024 - 30 Sep 2026
- Total cost
- €1 250 000,00
- Global Health EDCTP3 funding
- €1 250 000,00
- Call identifier
- HORIZON_HORIZON-JU-GH-EDCTP3-2024-Mpox
- Status
- In progress
- Project type
- Research and Innovation Actions (RIA)
- Disease area
- Emerging or re-emerging infectious diseases
- Intervention type
- Surveillance tools
Consortium map
Coordinator
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
- Location
- Rotterdam, Netherlands
- EU contribution
- €325 000,00
- Total cost
- €325 000,00
Beneficiaries
STANSILE LTD
- Location
- Nyarugenge, Rwanda
- EU contribution
- €420 000,00
- Total cost
- €420 000,00
RWANDA BIOMEDICAL CENTER
- Location
- Kigali, Rwanda
- EU contribution
- €40 000,00
- Total cost
- €40 000,00
DANMARKS TEKNISKE UNIVERSITET
- Location
- KONGENS LYNGBY, Denmark
- EU contribution
- €145 000,00
- Total cost
- €145 000,00
UNIVERSIDAD DE CASTILLA - LA MANCHA
- Location
- CIUDAD REAL, Spain
- EU contribution
- €25 000,00
- Total cost
- €25 000,00
THE GOOD SAMARITAN FOUNDATION
- Location
- MOSHI, Tanzania
- EU contribution
- €75 000,00
- Total cost
- €75 000,00
INSTITUT NATIONAL DE SANTE PUBLIQUE
- Location
- Bujumbura, Burundi
- EU contribution
- €75 000,00
- Total cost
- €75 000,00
UNIVERSITE CATHOLIQUE DE BUKAVU
- Location
- BUKAVU, Democratic Republic of the Congo
- EU contribution
- €145 000,00
- Total cost
- €145 000,00
Related projects
Supporting mpox responses and research in eastern DRCThe MBOTE-SK project is embedding research within the response to the new clade Ib mpox outbreak in eastern DRC.
Rapid protection against Ebola virusThe EBO-PEP project is evaluating whether monoclonal antibodies can protect close contacts of people with Ebola virus infections.
Pregnant women have an increased risk of severe mpox disease, however, the underlying mechanisms remain elusive. To better understand altered transmission pattern of MPXV and its impact on...